Kacy S. Yount

Bps polysaccharide of Bordetella pertussis resists antimicrobial peptides by functioning as a dual surface shield and decoy and converts Escherichia coli into a respiratory pathogen

P. Howell, K. Corps, P. Dubey, 2022, bioRxiv.

Bordetella Colonization Factor A (BcfA) Elicits Protective Immunity against Bordetella bronchiseptica in the Absence of an Additional Adjuvant

K. Corps, S. Quataert, P. Dubey, 2019, Infection and Immunity.

Whoop! There it is: The surprising resurgence of pertussis

P. Dubey, R. Deora, A. Fullen, 2020, PLoS pathogens.

Genetic susceptibility loci for Chlamydia trachomatis endometrial infection influence expression of genes involved in T cell function, tryptophan metabolism and epithelial integrity

Taylor B. Poston, T. Darville, S. Hillier, 2022, Frontiers in Immunology.

Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces B. pertussis nasal colonization

Yimin Huang, J. Maynard, S. Quataert, 2023, Frontiers in Immunology.

Unique T cell signatures are associated with reduced Chlamydia trachomatis reinfection in a highly exposed cohort

T. Darville, Chuwen Liu, S. Hillier, 2023, bioRxiv.

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice.

P. Dubey, R. Deora, Kacy S. Yount, 2019, Journal of visualized experiments : JoVE.

Viral-vectored boosting of OmcB or CPAF-specific T cell responses fail to enhance protection from Chlamydia muridarum in infection immune mice and elicits a non-protective CD8-dominant response in naïve mice.

Taylor B. Poston, T. Darville, N. Goonetilleke, 2024, Mucosal immunology.